drugset / Trial / NCT07159074

Repurposing Tilmanocept for Cardiac Sarcoidosis

NCT07159074

NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study is to see if Tc 99m Tilmanocept SPECT/CT imaging can be used to identify cardiac sarcoidosis.

Timeline

Start
2025-09-17
Primary completion
2026-12-01
Completion
2026-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Technetium Tc 99m Tilmanocept Diagnostic / imaging agent 150 ug Intravenous
Subject Technetium Tc 99m Tilmanocept Diagnostic / imaging agent 370 mbq Intravenous

Indications